ESCRS president Filomena Ribeiro invites ASCRS attendees to 'cataract Olympiad' after successful Refractive Day

News
Video

Filomena Ribeiro, MD, PhD, FEBO, discusses her presentation on neuroadaptation following the ASCRS Refractive Day

During the first day of the 2024 ASCRS meeting, attendees could enjoy select presentations as part of the refractive subspecialty day. Filomena Ribeiro, MD, PhD, FEBO, is president of the ESCRS. She shared talking points from her presentation on neuroadaptation with Ophthalmology Times Europe, and invited friends and colleagues to the upcoming ESCRS Congress in Barcelona, Spain, this September.

Editor's note: The following transcript has been lightly edited for clarity.

Hi, I'm Filomena Ribeiro. I'm the president of ESCRS And today, we are here in Boston, in the celebration of the anniversary of ASCRS, sharing our experience with our colleagues. So, today was Refractive Day, and we had a special session, which was amazing because almost all [the speakers] were women. It was great to see the session. And we touched on several points about the new designs of the IOLs, and also the problems that we can have in the post-op.

My talk was about neuroadaptation, which is, well, like a mystery issue right now. We still have a lot to know about this process, but it really exists, and there is proofs of the the stimulation of the brain's learning areas after the the implantation of bilateral trifocals, for instance. That is something that provides also the ability of patients to neuroadapt, I showed some some data about binocular summation, which is also very relevant for the type of design of the intraocular lenses. Because we know that the binocular summation is more relevant for multifocal IOLs compared with a monofocal IOL. So, yes, sometimes we need to be patient. We need to explain everything to our patients, and wait for the process of neuroadaptation.

I really would like to invite you all to go to the session of the Olympics [the ASCRS "Cataract Olympiad" event on Sunday, 7 April, at 1330], where ESCRS will debate the "football team" with all of you. And this year, ESCRS will have the main congress in Barcelona, which is an amazing city. We'll have hot, not the cold of Boston, and it will be a great congress with very new initiatives. We'll have big societies also represented in the combined sessions, and I think you will love to be there with all of us. Please, I would like to invite you all to come in September to the Congress of ESCRS in Barcelona.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.